U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H45N3O3
Molecular Weight 423.6324
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GALLAMINE

SMILES

CCN(CC)CCOC1=CC=CC(OCCN(CC)CC)=C1OCCN(CC)CC

InChI

InChIKey=ICLWTJIMXVISSR-UHFFFAOYSA-N
InChI=1S/C24H45N3O3/c1-7-25(8-2)16-19-28-22-14-13-15-23(29-20-17-26(9-3)10-4)24(22)30-21-18-27(11-5)12-6/h13-15H,7-12,16-21H2,1-6H3

HIDE SMILES / InChI
Gallamine is a synthetic non-depolarizing neuromuscular blocking agent. It has been used to produce relaxation of skeletal muscle during surgery.

Originator

Approval Year

PubMed

PubMed

TitleDatePubMed
Mechanism of action of gallamine.
1980-07
Passage of gallamine from blood into the liquor space in man and in dog.
1973-08
Patents

Sample Use Guides

Muscle relaxants should be administered only after induction of anaesthesia and when a secure airway has been established. The dosage must be adjusted according to the response. As a guide: Adults: 1-1.5 mg/kg i.v. initially, then 0.5-1 mg/kg as required at about 40-minute intervals. Children: 1.5 mg/kg initially, then 0.5 mg/kg as required. Infants of less than 1 month: 250-750 micrograms/kg initially, then 100-500 micrograms/kg as required.
Route of Administration: Intravenous
In Vitro Use Guide
The mechanisms of action of gallamine on nerve terminals, cholinergic receptors, and the threshold for propagation of end-plate potentials to the muscle fiber were investigated in rat phrenic nerve-diaphragm preparations. Intracellular studies were made with glass microelectrodes to determine changes in end-plate potentials and miniature end-plate potentials produced by gallamine at concentrations between 0.1 uM to 100 uM.
Name Type Language
GALLAMINE
WHO-DD  
Common Name English
Gallamine [WHO-DD]
Preferred Name English
2,2',2''-(BENZENE-1,2,3-TRIYLTRI(OXY))TRIS(N,N-DIETHYLETHYLAMINE)
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66880
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
WHO-ATC M03AC02
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
WHO-VATC QM03AC02
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
Code System Code Type Description
RXCUI
4638
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY RxNorm
IUPHAR
356
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
PUBCHEM
67425
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
SMS_ID
100000087237
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
NCI_THESAURUS
C87604
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-816-2
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
DRUG BANK
DB13584
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID60165184
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
FDA UNII
1146X1WTNM
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
DRUG CENTRAL
1273
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
CHEBI
503442
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
EVMPD
SUB02305MIG
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
ChEMBL
CHEMBL360055
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY
CAS
153-76-4
Created by admin on Mon Mar 31 18:40:49 GMT 2025 , Edited by admin on Mon Mar 31 18:40:49 GMT 2025
PRIMARY